{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:28:20Z","timestamp":1759624100714,"version":"build-2065373602"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ejogrb.2023.11.008","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T03:31:43Z","timestamp":1699500703000},"page":"44-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Counselling and management of women with genetic predisposition to gynaecological cancers"],"prefix":"10.1016","volume":"294","author":[{"given":"Naushabah","family":"Malik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banchhita","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2023.11.008_b0005","first-page":"411","article-title":"A population-based study of endometrial cancer and familial risk in younger women. Cancer and Steroid Hormone Study Group","volume":"5","author":"Gruber","year":"1996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0010","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/PPO.0b013e31826246c2","article-title":"Genetic testing by cancer site: ovary","volume":"18","author":"Weissman","year":"2012","journal-title":"Cancer J"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0015","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0020","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00004347-199207000-00003","article-title":"Hereditary ovarian cancer: a clinicopathological study","volume":"11","author":"Bewtra","year":"1992","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0025","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.gde.2010.03.001","article-title":"The inherited genetics of ovarian and endometrial cancer","volume":"20","author":"Gayther","year":"2010","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0030","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0035","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/379749a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2","volume":"379","author":"Wooster","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0040","first-page":"265","article-title":"Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium","volume":"56","author":"Easton","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0045","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0050","unstructured":"National Institute for Health and Care Excellence. Familial breast cancer: classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer. NICE Clinical Guideline 164. Manchester: NICE; 2013."},{"key":"10.1016\/j.ejogrb.2023.11.008_b0055","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","article-title":"Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer \u2013 shifting the paradigm","volume":"42","author":"Kurman","year":"2011","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0060","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/IGC.0b013e3181dbd1a5","article-title":"Moving toward personalized medicine: treatment-focused genetic testing of women newly diagnosed with ovarian cancer","volume":"20","author":"Trainer","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0065","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/GIM.0b013e3181ab2295","article-title":"Timing of BRCA1\/BRCA2 genetic testing in women with ovarian cancer","volume":"11","author":"Daniels","year":"2009","journal-title":"Genet Med"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0070","unstructured":"Mainstreaming Cancer Genetics programme. Available at: http:\/\/mcgprogramme.com\/] (last accessed 20 October 2014)."},{"key":"10.1016\/j.ejogrb.2023.11.008_b0075","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/0092-8674(93)90330-S","article-title":"Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer","volume":"75","author":"Leach","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0080","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0092-8674(93)90546-3","article-title":"The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer","volume":"75","author":"Fishel","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0085","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1126\/science.8128251","article-title":"Mutation of a mutL homolog in hereditary colon cancer","volume":"263","author":"Papadopoulos","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0090","first-page":"5068","article-title":"Germ-line msh6 mutations in colorectal cancer families","volume":"59","author":"Kolodner","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0095","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra012242","article-title":"Hereditary colorectal cancer","volume":"348","author":"Lynch","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/j.gastro.2004.03.068","article-title":"Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance","volume":"127","author":"Hendriks","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0105","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<214::AID-IJC8>3.0.CO;2-L","article-title":"Cancer risk in mutation carriers of DNA-mismatch-repair genes","volume":"81","author":"Aarnio","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0110","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/gyno.2001.6279","article-title":"The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer","volume":"82","author":"Watson","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0115","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0016-5085(99)70510-X","article-title":"New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC","volume":"116","author":"Vasen","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djh034","article-title":"Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability","volume":"96","author":"Umar","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0125","first-page":"5248","article-title":"A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer","volume":"58","author":"Boland","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0130","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ygyno.2005.10.029","article-title":"The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer","volume":"101","author":"Malander","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0135","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0002-9378(98)70476-4","article-title":"BRCA1, BRCA2, and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing","volume":"178","author":"Rubin","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0140","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1200\/JCO.2007.10.8597","article-title":"Prospective determination of prevalence of Lynch syndrome in young women with endometrial cancer","volume":"25","author":"Lu","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0145","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1200\/JCO.2003.04.094","article-title":"Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis","volume":"21","author":"Berends","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0150","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1200\/JCO.2005.06.055","article-title":"Molecular analysis of familial endometrial carcinoma: a manifestation of hereditary nonpolyposis colorectal cancer or a separate syndrome?","volume":"23","author":"Ollikainen","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0155","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/gutjnl-2012-304356","article-title":"Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts","volume":"62","author":"Vasen","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMoa052627","article-title":"Prophylactic surgery to reduce the risk of gynecologic cancers in Lynch syndrome","volume":"354","author":"Schmeler","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0165","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials","volume":"376","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0170","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/S0140-6736(11)61049-0","article-title":"CAPP2 Investigators. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial","volume":"378","author":"Burn","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0175","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/1078-0432.CCR-11-2283","article-title":"Lifetime cancer risks in individuals with germline PTEN mutations","volume":"18","author":"Tan","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0180","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/jmg.2011.088807","article-title":"Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan\u2013Riley\u2013Ruvalcaba syndrome clinical features","volume":"48","author":"Pilarski","year":"2011","journal-title":"J Med Genet"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0185","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/PPO.0b013e3182610cc2","article-title":"Genetic testing by cancer site: uterus","volume":"18","author":"Daniels","year":"2012","journal-title":"Cancer J"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0190","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.cgh.2005.11.005","article-title":"Peutz-Jeghers syndrome and management recommendations","volume":"4","author":"Giardiello","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0195","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0200","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2014.09.009","article-title":"SGO Clinical Practice Committee. Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions","volume":"136","author":"Lancaster","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0205","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/jnci\/djt277","article-title":"Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria","volume":"105","author":"Pilarski","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0210","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1200\/JCO.2004.06.090","article-title":"Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1\/2 mutations: a decision analysis","volume":"22","author":"Armstrong","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0215","doi-asserted-by":"crossref","unstructured":"Mutch D, Denny L, Qinn M; FIGO Committee on Gynecologic Oncology. Hereditary gynecologic cancers. Int J Gynaecol Obstet 2014:124;189\u201392.","DOI":"10.1016\/j.ijgo.2013.12.001"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0220","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","article-title":"Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation","volume":"296","author":"Finch","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0225","series-title":"Hereditary gynecologic cancer: risk, prevention, and management","first-page":"79","article-title":"Risk-reducing salpingooophorectomy for the prevention of inherited breast and ovarian cancer","author":"Lewin","year":"2008"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0230","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ygyno.2005.01.039","article-title":"Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations","volume":"97","author":"Casey","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0235","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1200\/JCO.2004.00.7138","article-title":"Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case\u2013control study","volume":"23","author":"Eisen","year":"2005","journal-title":"J Clin Oncol"},{"issue":"140","key":"10.1016\/j.ejogrb.2023.11.008_b0240","first-page":"e1","article-title":"Oophorectomy as a risk factor for coronary heart disease","volume":"200","author":"Jacoby","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0245","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.1200\/JCO.2005.02.626","article-title":"Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer","volume":"23","author":"Madalinska","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0250","series-title":"Hereditary gynecologic cancer: risk, prevention, and management","first-page":"45","article-title":"Ovarian cancer screening","author":"Cass","year":"2008"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0255","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0260","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/djn442","article-title":"Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers","volume":"101","author":"Rebbeck","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0265","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prevention and observation of surgical end points study group. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0270","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","article-title":"Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study","volume":"26","author":"Kauff","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0275","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.AOG.0000267500.27329.85","article-title":"Gynecologic cancer prevention in Lynch syndrome\/hereditary nonpolyposis colorectal cancer families","volume":"110","author":"Chen","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0280","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0285","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0290","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.molonc.2009.02.001","article-title":"The contribution of BRCA1 and BRCA2 to ovarian cancer","volume":"3","author":"Ramus","year":"2009","journal-title":"Mol Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0295","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0300","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/jnci\/djab036","article-title":"Endometrial cancer risk in women with germline brca1 or brca2 mutations: multicenter cohort study","volume":"113","author":"De Jonge","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0305","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/jnci\/djab037","article-title":"BRCA1\/2 and endometrial cancer risk: implications for management","volume":"113","author":"Sherman","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0310","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/GRF.0b013e318218c755","article-title":"Uterine papillary serous carcinoma","volume":"54","author":"Moore","year":"2011","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0315","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","article-title":"Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers","volume":"91","author":"Easton","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0320","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/IGC.0b013e3181ef622d","article-title":"BRCA1\/2 germline mutations in Jewish patients with uterine serous carcinoma","volume":"20","author":"Bruchim","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0325","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1200\/JCO.2013.51.2129","article-title":"Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing","volume":"32","author":"Buchanan","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0330","first-page":"1702","article-title":"Association of mismatch repair mutation with age at cancer onset in lynch syndrome: Implications for stratified surveillance strategies","volume":"3","author":"Ryan","year":"2017","journal-title":"JAMAOncol"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0335","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations inMLH1, MSH2, and MSH6 genes in Lynch syndrome","volume":"305","author":"Bonadona","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0340","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/gutjnl-2017-314057","article-title":"Cancer risk and survival in path MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database","volume":"67","author":"M\u00f8ller","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0345","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1038\/s41436-019-0489-y","article-title":"The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome","volume":"21","author":"Crosbie","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.ejogrb.2023.11.008_b0350","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10689-013-9674-3","article-title":"Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome","volume":"13","author":"Nieuwenhuis","year":"2013","journal-title":"Fam Cancer"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211523008084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211523008084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T06:03:17Z","timestamp":1759557797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211523008084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":70,"alternative-id":["S0301211523008084"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2023.11.008","relation":{},"ISSN":["0301-2115"],"issn-type":[{"type":"print","value":"0301-2115"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Counselling and management of women with genetic predisposition to gynaecological cancers","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2023.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}